Remove tag patient-groups
article thumbnail

Healthcare doesn’t give a damn about patients

World of DTC Marketing

A new analysis released Wednesday by Patients for Affordable Drugs estimates that pharmaceutical companies in the U.S. Patients for Affordable Drugs found that between June 24 and July 5, pharmaceutical companies increased prices for 133 products. have raised drug prices 1,186 times so far this year. But they’re not alone.

article thumbnail

The Ultimate Guide to Healthcare SEO: 3 Techniques Your Website's Organic Marketing Needs

Healthcare Success

A successful health system, hospital, practice, or healthcare organization website facilitates patient communication and helps you win more of the patients you want. But this doesn’t mean much if patients can’t find your website. Siloing is an SEO technique where you group, isolate and interlink content about a specific topic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

SKIMMERS SUMMARY: Jefferies analysts found doctors have shown strong interest in prescribing Aduhelm for about 35% of early-stage Alzheimer’s patients with mild cognitive impairment after surveying 50 U.S. neurologists or psychiatrists currently treating about 12,000 Alzheimer’s patients. Not to mention the $56,000 annual price tag.

FDA 218
article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

AI is also making waves in how to find and target patient communities as healthcare privacy legislation continues to expand in the United States. Dstillery, a custom audience solution, predicts impression opportunities through AI modeling that identifies patient patterns without using any cookie-based identification.

article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

With a focus on patient-centricity, data-driven insights, and collaborative partnerships across the healthcare ecosystem, it’s redefining the playbook for market shaping and building advocacy for a product pre- and post-launch. Medical Affairs is at the forefront of this paradigm shift.

Medical 52
article thumbnail

ASH: Argenx cues up a second use for efgartigimod

pharmaphorum

Updated results from the ADVANCE IV study of Vyvgart (efgartigimod alfa) showed that more than half of patients with ITP treated with Argenx’ drug showed an improvement in platelet counts, which are dramatically reduced in the disorder. After 24 weeks, 21.8% After 24 weeks, 21.8% All told, 51.2%

article thumbnail

Do healthcare mergers and acquisitions lead to better care for patients?

Clarify Health

Today’s healthcare providers are seeing significantly more patients than they did a decade ago – many of whom are often sicker and have more complex care needs. These patients have evolving and growing needs and expectations for the quality of care delivered and overall patient experience.

Leads 52